New estimation method for highly sensitive quantitation of human immunodeficiency virus type 1 DNA and its application

Journal of Virological Methods

Volumn 124, Issue 1-2, 2005, Pages 157-165

  Nagai, Hiromi ^a,b   Wada, Kaoru ^a   Morishita, Takayuki ^c   Utsumi, Makoto ^a   Nishiyama, Yukihiro ^b   Kaneda, Tsuguhiro ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

HAART; Highly sensitive quantitation; HIV 1 DNA; real time PCR

Indexed keywords

ANTIRETROVIRUS AGENT; BETA 2 MICROGLOBULIN; VIRUS DNA;

ACCURACY; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MALE; MICROBIAL POPULATION DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12344330423     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2004.11.025     Document Type: Article

References (21)

1. 6/l CD4 cells treated with highly active antiretroviral therapy AIDS 14 2000 23 29
2. E. Beillard, N. Pallisgaard, V.H. van der Velden, W. Bi, R. Dee, E. van der Schoot, E. Delabesse, E. Macintyre, E. Gottardi, G. Saglio, F. Watzinger, T. Lion, J.J. van Dongen, P. Hokland, and J. Gabert Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program Leukemia 17 2002 2474 2486
3. T.W. Chun, L. Stuyver, S.B. Mizell, L.A. Ehler, J.A.M. Mican, M. Baseler, A.L. Lloyd, M.A. Nowak, and A.S. Fauci Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy Proc. Natl. Acad. Sci. U.S.A. 94 1997 13193 13197
4. T.W. Chun, J.S. Justement, R.A. Lempicki, J. Yang, G. Dennis Jr., C.W. Hallahan, C. Sanford, P. Pandya, S. Liu, M. Mclaughlin, L.A. Ehler, S. Moir, and A.S. Fauci Gene expression and viral production in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-1 infected individuals Proc. Natl. Acad. Sci. U.S.A. 100 4 2003 1908 1913
5. F. Damond, D. Descamps, I. Farfara, J.N. Telles, P. Campa, A. Lepretre, S. Metheron, F. Brun-Vezinet, and F. Simon Quantification of proviral load of human immunodeficiency virus type 2 subtype A and B using real-time PCR J. Clin. Microbiol. 39 2001 4264 4268
6. N. Désiré, A. Dehee, V. Schneider, C. Jacomet, C. Goujon, P.M. Girard, W. Rozenbaum, and J.C. Nicolas Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR J. Clin. Microbiol. 39 2001 1303 1310
7. T.M. Folks, K.A. Clouse, J. Justement, A. Rabson, E. Duh, J.H. Kehrl, and A.S. Fauci Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone Proc. Natl. Acad. Sci. U.S.A. 86 1989 2365 2368
8. A. Ibanez, T. Puig, J. Elias, B. Clotet, R. Lidia, and M.A. Martinez Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients AIDS 13 1999 1045 1049
9. J. Izopet, G. Salama, C. Pasquier, K. Sandres, B. Marchou, P. Massip, and J. Puel Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 1998 478 483
10. J.W. Mellors, C.R. Rinaldo Jr., P. Gupta, R.M. White, J.A. Todd, and L.A. Kigsley Prognosis in HIV-1 infection predicted by the quantity of virus in plasma Science 272 1996 1167 1170
11. N. Ngo-Giang-Huong, C. Deveau, I. Da Silva, I. Pellegrin, A. Venet, M. Harzic, M. Sinet, J-F. Delfraissy, L. Meyer, C. Goujard, and C. Rouzioux Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy AIDS 15 2001 665 673
12. U. O'Doherty, W.J. Swiggard, D. Jeyakumar, D. McGain, and M.H. Malim A sensitive, quantitative assay for human immunodeficiency virus type 1 integration J. Virol. 76 2002 10942 10950
13. A.S. Perelson, P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. Ho Decay characteristics of HIV-1-infected compartments during combination therapy Nature 387 1997 188 191
14. R. Rasmussen Quantification on the LightCycler S. Meuer C. Wittwer K. Nakagawara Rapid Cycle Real-Time PCR: Methods and Applications 2001 Springer Berlin 21 34
15. E. Riva, M. Pistello, P. Narciso, G. D'Offizi, P. Isola, V. Galati, O. Turriziani, V. Tozzi, L. Vincenzi, and G. Antonelli Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy AIDS Res. Hum. Retroviruses 17 2001 1599 1604
16. E. Riva, G. Antonelli, D. Scagnolari, M. Pistello, M.R. Capobianchi, A. Monforte, P. Pezzotti, and F. Dianzani Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive HIV-1-infected patients J. Infect. Dis. 187 2003 1826 1828
17. M.E. Sharkey, I. Teo, T. Greenough, N. Sharova, K. Luzuriaga, J.L. Sullivan, R.P. Bucy, L.G. Kostrikis, A. Haase, C. Veryard, R.E. Davaro, S.H. Cheeseman, J.S. Daly, C. Bova, R.T. Ellison 3rd, B. Mady, K.K. Lai, G. Moyle, M. Nelson, B. Gazzard, S. Shaunak, and M. Stevenson Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy Nat. Med. 6 2000 76 81
18. K. Wada, H. Nagai, T. Hagiwara, S. Ibe, M. Utsumi, and T. Kaneda Delayed HIV-1 infection to CD4+ T lymphocytes was demonstrated by quantifying viral copy numbers in cells from therapy-naïve patients Microbiol. Immunol. 48 2004 767 772
19. N.J. Walker A technique whose time has come Science 296 2002 557 558
20. S. Yerly, T.V. Pernger, S. Vora, B. Hirschel, and L. Perrin Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection AIDS 14 2000 2805 2812
21. Y. Zhao, M. Yu, J.W. Miller, M. Chen, E.G. Bremer, W. Kabat, and R. Yogev Quantification of human immunodeficiency virus type 1 proviral DNA by Using TaqMan Technology J. Clin. Microbiol. 40 2002 675 678